Contrary to other studies, the research conducted by Tehrani et al. evaluating the combined blocking of TIGIT and PD-1 in CLL did not demonstrate a significant increase in CD8+ T cell proliferation and cytotoxicity compared to single treatments [178].. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.